Filed: 8/14/2025ACC: 0001622627-25-000028
📋 What this filing means
ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $210.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$210.89M
Total AUM (reported)
34.90M
Total Shares
Allocation by class
COM$102.49M48.6%
COM NEW$85.46M40.5%
SPONSORED ADS$10.81M5.1%
SHS NEW$7.88M3.7%
PUT$3.00M1.4%
CALL$1.24M0.6%
Portfolio Concentration
Top 3$63.20M30.0%
4–10$68.21M32.3%
11–25$73.30M34.8%
Rest$6.19M2.9%
Top 3 weight
30.0%
Top 10 weight
62.3%
Voting Authority Distribution
Total shares with voting rights: 34.90M
Sole
Full voting authority
34.90M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
DELCATH SYS INC
SOLEShares3.30M
TypeSH
Market value$33.00M
15.65%
Sole
3.30M
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares2.05M
TypeSH
Market value$16.98M
8.05%
Sole
2.05M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares400K
TypeSH
Market value$13.22M
6.27%
Sole
400K
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.22M
TypeSH
Market value$11.31M
5.36%
Sole
1.22M
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares511.13K
TypeSH
Market value$10.74M
5.09%
Sole
511.13K
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares2.16M
TypeSH
Market value$10.07M
4.77%
Sole
2.16M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares700K
TypeSH
Market value$9.79M
4.64%
Sole
700K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares100K
TypeSH
Market value$9.46M
4.48%
Sole
100K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares2.04M
TypeSH
Market value$8.48M
4.02%
Sole
2.04M
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares900K
TypeSH
Market value$8.36M
3.96%
Sole
900K
Shared
0.00
None
0.00
MEDIWOUND LTD
SOLEShares407.06K
TypeSH
Market value$7.88M
3.74%
Sole
407.06K
Shared
0.00
None
0.00
MYOMO INC
SOLEShares3.60M
TypeSH
Market value$7.77M
3.68%
Sole
3.60M
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.74M
TypeSH
Market value$7.77M
3.68%
Sole
1.74M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares542.37K
TypeSH
Market value$7.43M
3.52%
Sole
542.37K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares810.92K
TypeSH
Market value$6.80M
3.23%
Sole
810.92K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares2.65M
TypeSH
Market value$6.05M
2.87%
Sole
2.65M
Shared
0.00
None
0.00
INSPIREMD INC
SOLEShares2.29M
TypeSH
Market value$5.20M
2.46%
Sole
2.29M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares192.97K
TypeSH
Market value$5.02M
2.38%
Sole
192.97K
Shared
0.00
None
0.00
PROFOUND MED CORP
SOLEShares692.18K
TypeSH
Market value$4.08M
1.94%
Sole
692.18K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares223.63K
TypeSH
Market value$3.94M
1.87%
Sole
223.63K
Shared
0.00
None
0.00
POLYPID LTD
SOLEShares975.46K
TypeSH
Market value$3.44M
1.63%
Sole
975.46K
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares420K
TypeSH
Market value$2.73M
1.29%
Sole
420K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares157.72K
TypeSH
Market value$1.78M
0.85%
Sole
157.72K
Shared
0.00
None
0.00
INMUNE BIO INC
SOLEShares1.03M
TypeSH
Market value$1.76M
0.84%
Sole
1.03M
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$1.64M
0.78%
Sole
300K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DELCATH SYS INCSOLE | COM NEW | 3.30M | SH | $33.00M 15.65% | 3.30M | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 2.05M | SH | $16.98M 8.05% | 2.05M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 400K | SH | $13.22M 6.27% | 400K | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.22M | SH | $11.31M 5.36% | 1.22M | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 511.13K | SH | $10.74M 5.09% | 511.13K | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 2.16M | SH | $10.07M 4.77% | 2.16M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 700K | SH | $9.79M 4.64% | 700K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 100K | SH | $9.46M 4.48% | 100K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 2.04M | SH | $8.48M 4.02% | 2.04M | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 900K | SH | $8.36M 3.96% | 900K | 0.00 | 0.00 |
MEDIWOUND LTDSOLE | SHS NEW | 407.06K | SH | $7.88M 3.74% | 407.06K | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 3.60M | SH | $7.77M 3.68% | 3.60M | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.74M | SH | $7.77M 3.68% | 1.74M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 542.37K | SH | $7.43M 3.52% | 542.37K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 810.92K | SH | $6.80M 3.23% | 810.92K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 2.65M | SH | $6.05M 2.87% | 2.65M | 0.00 | 0.00 |
INSPIREMD INCSOLE | COM | 2.29M | SH | $5.20M 2.46% | 2.29M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 192.97K | SH | $5.02M 2.38% | 192.97K | 0.00 | 0.00 |
PROFOUND MED CORPSOLE | COM NEW | 692.18K | SH | $4.08M 1.94% | 692.18K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 223.63K | SH | $3.94M 1.87% | 223.63K | 0.00 | 0.00 |
POLYPID LTDSOLE | COM | 975.46K | SH | $3.44M 1.63% | 975.46K | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 420K | SH | $2.73M 1.29% | 420K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 157.72K | SH | $1.78M 0.85% | 157.72K | 0.00 | 0.00 |
INMUNE BIO INCSOLE | PUT | 1.03M | SH | $1.76M 0.84% | 1.03M | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 300K | SH | $1.64M 0.78% | 300K | 0.00 | 0.00 |
Page 1 of 2